Netherlands-based health technology firm Royal Philips has developed a new monitoring system IntelliVue X3 for use during in-hospital transport and at the bedside of patients.

Designed for continuous monitoring, the new system allows a smart-phone-style operation and is expected to address the concerns with incomplete data records and use of various systems during patient transport.

The system can be integrated into the firm’s IntelliVue Patient bedside and transport monitoring systems, clinical network and central stations.

The data from IntelliVue X3 can further be integrated into mobile applications, hospital network and interfaces connecting the system to other medical devices and the electronic medical record (EMR) system of the hospital.

Royal Philips Patient Care and Monitoring Solutions business leader Felix Baader said: "Health systems need accurate and transparent information and processes to help clinical staff make faster, more consistent decisions based on patient conditions and history.

“With the development of the IntelliVue X3, we're aiming to ensure that data isn't being lost during transitions and that we're able to better equip clinicians with the information they need, when they need it."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The new system facilitates monitoring of factors such as dual invasive blood pressure, built-in mainstream CO2 and ECG/arrhythmia as well as delivers scalable clinical measurements from both basic as well as advanced monitoring.

The IntelliVue X3 system has secured CE mark in Europe and is yet to be cleared by the US Food and Drug Administration (FDA).

Image: Patient being transferred with X3. Photo: courtesy of PRNewsfoto/Royal Philips.